Evidence map›Paper›PMID 40703279›Full record

ArticleFrontiers in medicine2025

Idiopathic mesenteric phlebosclerosis associated with use of Chinese patent medicine: a case report and literature review.

Li Lv, Ruo-Yu Gao, Xi-Qiu Yu

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Li Lv *Department of Gastroenterology, Shenzhen Luohu People's Hospital, Shenzhen, China.
Ruo-Yu Gao *Department of Gastroenterology, Shenzhen Luohu People's Hospital, Shenzhen, China.
Xi-Qiu YuDepartment of Gastroenterology, Shenzhen Luohu People's Hospital, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic Mesenteric Phlebosclerosis Colitis (IMP) is indeed a rare and potentially life-threatening condition characterized by chronic ischemic changes in the colon, primarily due to calcification of the mesenteric veins. This disease is often associated with long-term use of certain herbal medicines, particularly in Asian populations, where its prevalence is notably higher. This report describes a 55-year-old male patient who has been taking Chinese patent medicine orally for an extended period to treat prostatitis. His primary symptom is diarrhea. Imaging studies revealed multiple linear calcifications in the mesenteric veins surrounding the ascending and transverse colon. Colonoscopic findings showed bluish-purple discolored mucosa and multiple ulcers of the colonic and rectal mucosa. Pathological biopsy indicated fibrous tissue proliferation in the mucosal lamina propria and thickening of some blood vessel walls accompanied by hyaline degeneration. Based on clinical presentation, CT, colonoscopy, and histopathological findings, the final diagnosis was confirmed as IMP.

Indexed as

case reportChinese patent medicinecoloncolonoscopyidiopathic mesenteric phlebosclerotic colitis

Identifiers

PMID40703279
PMCPMC12283714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.